Southport Capital Management’s Novo Nordisk NVO Stock Holding History

Southport Capital Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$211K	Sell	3,808 -2,484	-39%	-$127K	0.08%	208
2021 Q4	$352K	Buy	6,292 +990	+19%	+$53.6K	0.06%	232
2021 Q3	$255K	Sell	5,302 -656	-11%	-$31.7K	0.1%	203
2021 Q2	$250K	Buy	+5,958	New	+$231K	0.06%	261
2018 Q4	–	Sell	-1,320	Closed	-$31K	–	394
2018 Q3	$31K	Buy	+1,320	New	+$32.2K	0.01%	298

Other funds holding NVO

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

Southport Capital Management's NVO Position: Q1 2022 in Review

Southport Capital Management reduced its Novo Nordisk (NVO) stake by 39% in Q1 2022, selling an estimated $127K and leaving 3,808 shares worth $211K. The position accounts for 0.08% of the portfolio, ranked #208.

Southport Capital Management first reported a position in NVO in Q3 2018 and has held it in 5 quarters since. The position peaked at $352K in Q4 2021. 901 funds tracked by Wall St. Rank hold NVO as of Q1 2022.

Southport Capital Management held 3,808 shares of Novo Nordisk worth $211K as of Q1 2022.
Southport Capital Management sold 2,484 Novo Nordisk shares in Q1 2022, an estimated $127K.
Novo Nordisk made up 0.08% of Southport Capital Management's portfolio in Q1 2022, its #208 holding.
Southport Capital Management first reported a position in Novo Nordisk in Q3 2018 and has held it in 5 quarters since.
Southport Capital Management's Novo Nordisk position peaked at $352K in Q4 2021.
901 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2022.

Based on Southport Capital Management's 13F filing for Q1 2022, filed 25 Apr 2022.